TLSA
Tiziana Life Sciences Ltd
Phase 2
AI-extracted
intranasal foralumab
non-active Secondary Progressive Multiple Sclerosis (na-SPMS)
T-minus 87 days
Oct 1, 2026
SEC 6-K
verified 11h ago
Countdown card →